Evidence map›Paper›PMID 37689641›Full record

ArticleBMC microbiology2023

Gut microbiome profile of Chinese hypertension patients with and without type 2 diabetes mellitus.

Hongying Ding, Yue Xu, Yinhong Cheng, Haoliang Zhou, Shiye Dong, Jian Wu, Jin Lv, Xiaosheng Hu, Oushan Tang

Abstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Depletion ofFrontiers in microbiology · 2026
    Article
  7. Article
  8. Chinese herbal medicines · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hongying Ding *Department of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Yue Xu *Shanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai, China.
Yinhong ChengDepartment of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Haoliang ZhouDepartment of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Shiye DongShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai, China.
Jian WuDepartment of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Jin LvDepartment of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Xiaosheng HuThe First Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, China.
Oushan TangDepartment of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China. tangoush@usx.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coexistence of hypertension and type 2 diabetes mellitus (T2DM) may largely increase the risk for cardiovascular disease. However, there is no clear consensus on the association between hypertension and the risk of diabetes. Gut microbiota plays important roles in the development of hypertension and T2DM, but whether there is difference between hypertension patients with or without T2DM has not been explored yet.

methodsWe recruited 101 hypertension patients in this study (72 patients without T2DM named HT group and 29 patients with T2DM named HT-T2DM group). Their blood samples were collected for testing clinical characteristics and fecal samples were tested for bacterial DNA using 16 S ribosomal RNA gene sequencing targeting the V3 and V4 region. The data of 40 samples were downloaded from project PRJNA815750 as health control (HC group) in this study. The community composition and structure of the microbiome, taxonomic difference, co-occurrence network and functional enrichment were analyzed by alpha/beta diversity, LEfSe, Fruchterman Reingold's algorithm and PICRUSt2 functional analysis, respectively.

resultsAlpha and beta diversity analysis showed significant differences in microbial community richness and composition among the three groups. The HC group had a significantly higher Simpson index and a distinct microbiota community compared to the HT and HT-T2DM groups, as demonstrated by significant differences in unweighted and weighted UniFrac distances. The LEfSe analysis identified specific taxa that had significantly different abundance among the groups, such as Bacteroides uniformis, Blautia wexlerae, Alistipes putredinis, and Prevotella stercorea in the HC group, Prevotella copri and Phascolarctobacterium faecium in the HT group, and Klebsiella pneumoniae in the HT-T2DM group. Co-occurrence network analysis indicates that Prevotella copri, Mediterraneibacter gnavus, Alistipes onderdonkii and some unidentified species act as key nodes in the network. Differentially functional pathway identified by PICRUSt2 were concentrated in nutrition and energy metabolism, as well as the biosynthesis of other secondary metabolites.

conclusionsOur study found significant differences in microbial community richness, composition, and function among the healthy controls, hypertension patients with and without T2DM. Some specific taxa may explain this difference and serve as potential therapeutic targets for hypertension, T2DM, and their coexistence.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeHypertensionEast Asian PeopleHumansPrevotella16S rRNA gene sequencingComorbidityGut microbiotaHypertensionType 2 diabetes mellitus

Identifiers

PMID37689641
PMCPMC10492291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.